Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity.
CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation.
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA TM*) in Multiple Sclerosis
Burden of neurological conditions in Canada.
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse Remitting Multiple Sclerosis
Alkali metals levels in the human brain tissue: Anatomical region differences and age-related changes.
Treatment with Trichuris suis soluble products during monocyte-to-macrophage differentiation reduces inflammatory responses through epigenetic remodeling.
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
Beta-Interferon, Glatiramer Acetate Cost-Effective in MS
LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.
Immunology 2016
Gordon Research Conference on In Vivo Magnetic Resonance
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Synaptic pathology: a shared mechanism in neurological disease.
A Complex Case of Neuro-Behçet's Disease in a Patient Previously Diagnosed with multiple Sclerosis: A Case Report.
Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.
Are changes in gait and balance across the Disease Step Rating Scale in Multiple Sclerosis statistically significant and clinically meaningful?
Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
Retinyl Palmitate Supplementation Modulates T-bet and Interferon Gamma Gene Expression in Multiple Sclerosis Patients.
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.
Peripheral Bilateral Telangiectasiae in Multiple Sclerosis Patients Treated with Interferon B1a.
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.
A case of multiple evanescent white dot syndrome misdiagnosed as optic neuritis: Differential diagnosis for the neurologist.
Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series.
Flupirtine in pain management: pharmacological properties and clinical use.

Pages